Parkinson's Disease Trial, Recruiting NCT03887663 Sponsor: Xiangya Hospital of Central South University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT03887663
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's disease using recognised standard diagnostic guidelines (known as the UK Brain Bank Diagnostic Criteria)

Who may not be able to join:

  • You are not able to give your own informed consent to take part in the study (for example, if you are unable to understand or agree to what the study involves)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8615874907260

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xiangya Hospital of Central South University
Registry
ClinicalTrials.gov
Start date
1 February 2017
Est. completion
1 February 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The Unified Parkinson's Disease Rating Scale for evaluating motor subtypes; The clinical stage of PD is assessed by Hoehn and Yahr scale; Autonomic symptoms are evaluated by The Scale for outcomes in Parkinson disease for Autonomic Symptoms; The non-motor symptoms are evaluated by Non-motor Symptom Scale; Constipation was diagnosed by Functional Constipation Diagnostic Criteria Rome III.; The PDQ-39 was used to assess the quality of life.; Sleep quality is evaluated by Parkinson's Disease Sleep Scale; Excessive sleepiness is evaluated by Epworth Sleepiness Scale; Probable rapid eye movement sl...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov